[
    "{\"step_by_step_thinking\": \"Panitumumab is a monoclonal antibody that targets the epidermal growth factor receptor (EGFR). It is used in the treatment of metastatic colorectal cancer. Biliary tract cancer, on the other hand, is a different type of cancer and there is no scientific evidence or clinical trials that suggest the use of Panitumumab for the treatment of biliary tract cancer. Therefore, it cannot be said that Panitumumab prolongs the survival of biliary tract cancer patients.\", \"answer_choice\": \"B. no\"}"
]